Trial Profile
The Neuromuscular Effect of Rocuronium in Patient Measuring Muscle Mass by Bioelectrical Impedance Analysis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 16 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 29 Jan 2016 New trial record